top of page
News
AmoyDx® Pan Lung Cancer PCR Panel application for approval in Japan as a Primary Companion Diagnostic for Taletrectinib
TOKYO and XIAMEN, March 27, 2025 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. (“AmoyDx”), and Precision Medicine Asia Co., Ltd....
Mar 28
AmoyDx® Pan Lung Cancer PCR Panel application for approval in Japan as a Companion Diagnostic for LORBRENA ® Lorlatinib
TOKYO and XIAMEN, February 6th, 2025 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. (“AmoyDx”), and Precision Medicine Asia Co.,...
Feb 6
NCC to initiate new research to develop nationwide Clinical Trial Network, LC-SCRUM-CD (Clinical Development), supported by PREMIA and Paradigm, to further accelerate precision medicine for patients.
The National Cancer Center (“NCC”), Precision Medicine Asia Co., Ltd. (“PREMIA”) and Paradigm Health Inc (“Paradigm”), announced the...
Nov 5, 2024
AmoyDx® Pan Lung Cancer PCR PanelApproved in Japan as a Companion Diagnosticfor AUGTYRO® (repotrectinib)
TOKYO and XIAMEN, September 25th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia...
Sep 25, 2024
AmoyDx® Pan Lung Cancer PCR PanelApproved in Japan as a Companion Diagnosticfor Haiyitan® tablets (gumarontinib hydrate)
TOKYO and XIAMEN, July 25th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
Jul 29, 2024
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for TABRECTA™ (Capmatinib)
TOKYO and XIAMEN, May 20th, 2024 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
May 20, 2024
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib...
TOKYO and XIAMEN, March 27, 2023 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
Mar 28, 2023
Premia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic..
Establishing a large-scale lung cancer genomic screening platform in the Asia-Pacific region and promoting precision medicine for lung...
Dec 21, 2022
AmoyDx® Pan Lung Cancer PCR PanelApprovedin Japan as a Companion DiagnosticforLUMAKRAS ®...
TOKYO and XIAMEN, November 14th, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
Nov 17, 2022
MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek®...
TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
Aug 9, 2022
Filing Notice for a Manufacturing and Marketing Application for AmoyDx® Pan LungCancer PCR Panel...
TOKYO and XIAMEN, April 20, 2022 -- Riken Genesis Co., Ltd., (“Rigen Genesis”), Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...
Apr 20, 2022
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval...
TOKYO and XIAMEN, February 23, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
Feb 24, 2022
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
Xiamen and Hong Kong, January 13, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK) Limited (“PREMIA”) today...
Jan 14, 2022
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO®
TOKYO and XIAMEN, August 17, 2021 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
Aug 17, 2021
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic...
TOKYO and XIAMEN, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...
Jun 30, 2021
PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
Hong Kong, China -- June 24, 2019 – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic...
Jun 24, 2019
LC-SCRUM Japan Expands Genomic Screening Project to Taiwan and Establishes LC-SCRUM Asia
The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project...
May 31, 2019
bottom of page